Immunic, Inc. (IMUX) Reports $42.3M Q3 Net Loss; Cash Runway Into Late 2027

Immunic reported a Q3 2026 net loss of approximately $42.3M, or $0.99 per share, versus $25.6M, or $1.32 per share, a year earlier. Cash was $132.0M at September 30, 2026, expected to fund operations into late 2027; ENSURE top-line data remain expected in December 2026.Material DetailsContext by AI…